Figure 2: Six weeks after second bevacizumab injection. Color fundus montage (a) shows consolidation of hard exudates and reduction in the sub-RPE mounds of hemorrhages in the temporal periphery (arrow). Indocyanine green angiography (b) reveals persistent polyps (arrows)